Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Can-Fite BioPharma Ltd. (CANF) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Can-Fite BioPharma Ltd. (CANF), most recent 12 months reported: revenue $405K, net loss $9.83M, free cash flow -$8.95M. Latest balance sheet on file: liquid cash $8.54M. From SEC filings. Others in Pharmaceutical Preparations: Silence Therapeutics plc · YARROW BIOSCIENCE, INC. · Quantum Cyber N.V. · MEREO BIOPHARMA GROUP PLC · PROVECTUS BIOPHARMACEUTICALS, INC. · CervoMed Inc. · Allarity Therapeutics, Inc. · REGEN BIOPHARMA, INC.

Stock screener

Watchlist